Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.
Hoth
D
D
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016047:Zalcitabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine